论文部分内容阅读
目的:观察痰热清注射液联合阿奇霉素序贯治疗小儿支原体肺炎的临床疗效及安全性。方法:选取76例小儿支原体肺炎患儿按照治疗方法不同分组为对照组与观察组,各38例。其中对照组采用阿奇霉素治疗,观察组于对照组治疗基础上采用痰热清注射液治疗。比较2组临床疗效、临床症状改善、住院时间、不良反应。结果:经治疗后,观察组总有效率为92.1%,明显高于对照组76.3%,差异有统计学意义(P<0.05);观察组咳嗽等临床症状改善时间及平均住院时间明显短于对照组,差异有统计学意义(P<0.05)。2组治疗期间未见明显性不良反应。结论:中药痰热清注射液联合阿奇霉素序贯治疗小儿支原体肺炎临床疗效显著。
Objective: To observe the Tanreqing injection combined with azithromycin sequential treatment of children with mycoplasma pneumonia clinical efficacy and safety. Methods: 76 cases of children with mycoplasma pneumonia were divided into control group and observation group according to different treatment methods, 38 cases in each group. The control group was treated with azithromycin, and the observation group was treated with Tanreqing Injection on the basis of the control group. The clinical efficacy, clinical symptoms, hospitalization time and adverse reactions of the two groups were compared. Results: After treatment, the total effective rate in the observation group was 92.1%, which was significantly higher than that in the control group (76.3%), the difference was statistically significant (P <0.05); the clinical symptoms improvement time and the average length of stay in the observation group were significantly shorter than those in the control group Group, the difference was statistically significant (P <0.05). No significant adverse reactions were observed during the two groups. Conclusion: Tanreqing injection combined with azithromycin sequential treatment of children with mycoplasma pneumonia clinical significant effect.